Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tiotropium bromide improves outcomes, QOL at acceptable cost
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
Tiotropium bromide reduces cost burden, improves QOL in COPD
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
Tiotropium bromide lessens cost burden, improves QOL in COPD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Deferasirox improves outcomes at acceptable cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. :